Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Asset disposition
Acq. announced
Director departure
|
|
MEI Pharma, Inc. (MEIP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/19/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 07/18/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 07/17/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 07/13/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 07/07/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 07/05/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 06/29/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 06/02/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/23/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 05/02/2011 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 03/10/2011 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 12/22/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
|
|